The CYP27B1 gene helps your kidneys and other tissues turn vitamin D into its active form, which lets the body absorb calcium and build strong bones. This gene plays an important role in keeping calcium levels steady, so harmful variants can cause vitamin D dependent rickets type 1A. People with this condition may have soft or painful bones, delayed growth, muscle weakness, or low calcium that can sometimes lead to seizures.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or regulate activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others are mainly involved in directing when, where, and to what extent certain processes take place. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this subject, you can find more information in the LearnHub.
Overview
CYP27B1Gene function
What if the gene works
The CYP27B1 gene helps your kidneys turn vitamin D into its active form. This supports calcium and phosphate balance and helps build and maintain strong bones.
Risk
What if the gene does not work
Variants in the CYP27B1 gene can partly or fully block activation of vitamin D, causing vitamin D-dependent rickets type 1A. Children often develop soft bones, poor growth, and low calcium, with earlier or more marked features in more severe variants.
Treatment
What does that mean for your treatment
A pathogenic loss-of-function variant in the CYP27B1 gene usually means treatment relies on active vitamin D, such as calcitriol or alfacalcidol, rather than standard vitamin D alone. Calcium supplements may also be needed. Follow-up helps keep calcium, phosphate, and urine calcium in a safe range while treatment is adjusted.
Conditions associated with CYP27B1
Gene function
What if the gene works
Your body depends on the CYP27B1 gene to turn vitamin D into its active form, the version your tissues can use. In your body, the CYP27B1 gene supports processes that keep calcium and phosphate available where they are needed most. This helps bones and teeth build and maintain their usual structure.
In the kidneys, the CYP27B1 gene converts the main circulating form of vitamin D into calcitriol (active vitamin D). This is the key step in how the CYP27B1 gene activates vitamin D for everyday use in the body.
Active vitamin D made through the CYP27B1 gene helps your intestines take in calcium and phosphate from food. This supports steady mineral levels in blood and other tissues.
By helping supply active vitamin D, the CYP27B1 gene supports bone mineralization, the process that gives bones and teeth their strength and structure. It helps calcium and phosphate move into these tissues in a controlled way.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYP27B1 gene can alter the enzyme's shape, stability, or amount, so cells convert less vitamin D into its active form. In practice, how CYP27B1 gene variants affect vitamin D activation depends on the change: milder variants may leave some enzyme activity, while more disruptive variants can greatly reduce or stop it. This functional range often influences how early vitamin D dependent rickets type 1A appears and how marked the features are.
How variants are linked to conditions
Pathogenic variants in the CYP27B1 gene cause vitamin D-dependent rickets type 1A, an inherited form of rickets linked to the CYP27B1 gene. People with this condition may develop soft bones, poor growth, muscle weakness, or low calcium levels, often starting in infancy or early childhood. Finding two disease-causing variants, one from each parent, can confirm the diagnosis. Carriers usually do not have symptoms.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely seen across the general population. Most do not directly affect health and simply reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In other situations, though, one well-characterized variant in a particular gene may be enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For CYP27B1, risk is mostly determined by inheritance: a child is affected when both copies of the gene have disease-causing changes. The chance is higher when both parents carry a CYP27B1 change, often because the change runs in the family. There is not enough evidence to say that diet, exercise, or other lifestyle steps change this inherited risk.
Inheritance of CYP27B1 variants
CYP27B1 gene variants linked to CYP27B1 related vitamin D dependent rickets type 1A are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the CYP27B1 gene from each parent. Parents who carry one variant are typically unaffected carriers, and when both parents are carriers, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. This is the main answer to how CYP27B1 gene variants are inherited.
What does my CYP27B1 result mean for my family?
For CYP27B1, family implications are usually linked to an inherited condition that runs in a recessive way. This often means both parents are healthy carriers, and brothers or sisters may also be affected or may carry the same gene change without symptoms. Other relatives can sometimes be carriers too, so this result may be relevant for family planning in the wider family.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the CYP27B1 gene usually uses a blood sample or cheek swab. This kind of CYP27B1 genetic testing reads the gene's DNA code to look for changes, and the report may show whether a variant helps confirm a diagnosis, explains carrier status, or needs expert interpretation.
When should I consider getting a genetic test?
Genetic testing for the CYP27B1 gene can be worth considering when a baby, child, or adult has signs of inherited vitamin D-related rickets, such as poor growth, bone pain, bowed legs, muscle weakness, or repeated low calcium levels. It can also help when these problems run in the family or when standard vitamin D treatment has not worked as expected.
A genetic result is only one part of your health story
A genetic result can provide meaningful insight, but how much it explains varies based on the condition and the type of variant involved. Lifestyle, environment, age, and medical history are among the many factors that influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. These differences are common and can influence how much benefit a medicine gives or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect how strongly a drug works or how the body handles it. This understanding can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the CYP27B1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted, so general questions about symptoms, supplements, or medication side effects are best discussed with your doctor. CYP27B1 has been studied in relation to vitamin D activation and response to vitamin D-related treatment, but this research has not led to standard prescribing guidance.
History
Doctors first recognized families with a rare form of vitamin D dependent rickets long before the CYP27B1 gene was identified. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition helped connect kidney vitamin D processing with inherited bone disease. In the 1970s and 1980s, researchers narrowed the problem to the missing 1α-hydroxylase step, and by the late 1990s the CYP27B1 gene was cloned and mapped. That discovery gave a clear genetic explanation for vitamin D dependent rickets type 1A. From these first observations, research expanded steadily. The CYP27B1 gene then became part of the broader story of how inherited variants can shape vitamin D biology and bone health.